Market Overview

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Share:
Related TEVA
Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's Generic Nexium
Benzinga's Weekend M&A Chatter
FDA clears abuse-deterrent formulation of Zohydro (Seeking Alpha)

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

Posted-In: News Financing

 

Related Articles (TEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional